Mostrar el registro sencillo del ítem

dc.contributor.authorRuiz-Garcia, Antonio
dc.contributor.authorPallarés-Carratalá, Vicente
dc.contributor.authorTurégano-Yedro, Miguel
dc.contributor.authorTorres, Ferran
dc.contributor.authorSapena, Víctor
dc.contributor.authorMartin-Gorgojo, Alejandro
dc.contributor.authorMartin-Moreno, Jose M.
dc.date.accessioned2023-04-18T11:09:46Z
dc.date.available2023-04-18T11:09:46Z
dc.date.issued2023-04-07
dc.identifier.citationRuiz-García, A.; Pallarés-Carratalá, V.; Turégano-Yedro, M.; Torres, F.; Sapena, V.; Martin-Gorgojo, A.; Martin-Moreno, J.M. Vitamin D Supplementation and Its Impact on Mortality and Cardiovascular Outcomes: Systematic Review and Meta-Analysis of 80 Randomized Clinical Trials. Nutrients 2023, 15, 1810.ca_CA
dc.identifier.issn2072-6643
dc.identifier.urihttp://hdl.handle.net/10234/202190
dc.description.abstractBackground: The impact of vitamin D supplementation on cardiovascular outcomes and mortality risk reduction remains unclear due to conflicting study findings. Methods: We conducted a systematic review and meta-analysis of randomized controlled trials (RCTs), published between 1983 and 2022, that reported the effect of vitamin D supplementation in adults versus placebo or no treatment on all-cause mortality (ACM), cardiovascular mortality (CVM), non-cardiovascular mortality (non-CVM), and cardiovascular morbidities. Only studies with a follow-up period longer than one year were included. The primary outcomes were ACM and CVM. Secondary outcomes were non-CVM, myocardial infarction, stroke, heart failure, and major or extended adverse cardiovascular events. Subgroup analyses were performed according to low-, fair- and good-quality RCTs. Results: Eighty RCTs were assessed, including 82,210 participants receiving vitamin D supplementation and 80,921 receiving placebo or no treatment. The participants’ mean (SD) age was 66.1 (11.2) years, and 68.6% were female. Vitamin D supplementation was associated with a lower risk of ACM (OR: 0.95 [95%CI 0.91–0.99] p = 0.013), was close to statistical significance for a lower risk of non-CVM (OR: 0.94 [95%CI 0.87–1.00] p = 0.055), and was not statistically associated with a lower risk of any cardiovascular morbi-mortality outcome. Meta-analysis of low-quality RCTs showed no association with cardiovascular or non-cardiovascular morbi-mortality outcomes. Conclusions: The emerging results of our meta-analysis present evidence that vitamin D supplementation appears to decrease the risk of ACM (especially convincing in the fair- and good-quality RCTs), while not showing a decrease in the specific cardiovascular morbidity and mortality risk. Thus, we conclude that further research is warranted in this area, with well-planned and executed studies as the basis for more robust recommendations.ca_CA
dc.format.extent16 p.ca_CA
dc.format.mimetypeapplication/pdfca_CA
dc.language.isoengca_CA
dc.publisherMDPIca_CA
dc.relation.isPartOfNutrients 2023, Vol. 15 (8)ca_CA
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/ca_CA
dc.subjectvitamin Dca_CA
dc.subjectall-cause mortalityca_CA
dc.subjectcardiovascular mortalityca_CA
dc.subjectmyocardial infarctionca_CA
dc.subjectstrokeca_CA
dc.subjectheart failureca_CA
dc.subjectmajor adverse cardiovascular eventsca_CA
dc.subjectsystematic reviewca_CA
dc.subjectmeta-analysisca_CA
dc.titleVitamin D supplementation and Its impact on mortality and cardiovascular outcomes: systematic review and meta-analysis of 80 randomized clinical trialsca_CA
dc.typeinfo:eu-repo/semantics/articleca_CA
dc.identifier.doihttps://doi.org/10.3390/nu15081810
dc.rights.accessRightsinfo:eu-repo/semantics/openAccessca_CA
dc.type.versioninfo:eu-repo/semantics/publishedVersionca_CA
dc.subject.ods3. Salud y bienestar


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

http://creativecommons.org/licenses/by/4.0/
Excepto si se señala otra cosa, la licencia del ítem se describe como: http://creativecommons.org/licenses/by/4.0/